Clinical Trials Insight: 700033169
Phase of Trial: Phase I
Latest Information Update: 30 May 2009
At a glance
- Drugs ADX-10059 (Primary)
- Indications Anxiety; Gastro-oesophageal reflux; Migraine
- Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
- Sponsors Addex Therapeutics
- 30 May 2009 Results for part 2 have been presented at Digestive Disease Week 2009.
- 10 Sep 2008 Status changed from recruiting to completed.
- 10 Sep 2008 Results reported by Addex Pharmaceuticals